Home>Topics>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Hunt for AIDS cure accelerates as GSK and U.S. experts link up

    Headlines

    Sun, 10 May 2015

    LONDON, May 11 (Reuters) - Britain's GlaxoSmithKline , which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.

  2. BRIEF- Glaxosmithkline Consumer Healthcare March-qtr profit rises

    Headlines

    Fri, 8 May 2015

    * says March-quarter net profit 1.97 billion rupees Source text: http://bit.ly/1F3DFqP

  3. UPDATE 2-New GSK chairman backs CEO Witty to stay at helm

    Headlines

    Thu, 7 May 2015

    LONDON, May 7 (Reuters) - GlaxoSmithKline 's new chairman Philip Hampton has thrown his support behind the company's current structure and chief executive despite pressure from some shareholders for a...

  4. New GSK chairman backs CEO Witty to stay at helm

    Headlines

    Thu, 7 May 2015

    LONDON, May 7 (Reuters) - GlaxoSmithKline 's new chairman Philip Hampton expressed support for the company's current structure and its chief executive on Thursday while speaking to reporters after the drugmaker's annual meeting.

  5. GSK sees little prospect of U.S. generic Advair in 2016

    Headlines

    Wed, 6 May 2015

    LONDON, May 6 (Reuters) - After relying for years on its top-selling lung drug Advair, GlaxoSmithKline is now braced for the worst in the form of cheap generics - but not just yet.

  6. BRIEF- GlaxoSmithKline CEO comments from media roundtable

    Headlines

    Wed, 6 May 2015

    * Ceo says ~has different view from other companies on further drug pricing pressures

  7. GlaxoSmithKline targets growth across units, scraps ViiV IPO

    Headlines

    Wed, 6 May 2015

    LONDON, May 6 (Reuters) - GlaxoSmithKline laid out growth targets for its biggest businesses on Wednesday, hoping to convince investors that focusing on consumer health and vaccines would return the drugmaker to long-term growth.

  8. BRIEF- GlaxoSmithkline sees 2015 earnings fall before pick-up

    Headlines

    Wed, 6 May 2015

    * Group revenue expected to grow at a cagr of low-to-mid single digits over five year period 2016-2020 on cer basis

  9. Gene therapy takes step forward as GSK files for EU approval

    Headlines

    Tue, 5 May 2015

    LONDON, May 5 (Reuters) - GlaxoSmithKline said on Tuesday it had submitted a gene therapy for approval in Europe, becoming the first big drugmaker to seek marketing authorisation for the technology to fix faulty genes.

  10. CORRECTED-U.S. FDA approves Glaxo, Theravance's Breo Ellipta asthma drug

    Headlines

    Fri, 1 May 2015

    April 30 (Reuters) - The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said.

« Prev12345Next »
Content Partners